Microbot Medical Files Q2 2026 10‑Q, Releases Q2 Highlights

What Happened

• On August 11, 2026, Microbot Medical Inc. announced via an 8-K (Regulation FD disclosure) that it filed its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026 and disseminated a press release summarizing highlights from the second quarter of 2026. The press release is furnished as Exhibit 99.1 and is incorporated by reference in the filing.

Key Details

• Filing date: August 11, 2026 (8-K announcing the Form 10-Q filing).
• Reporting period: Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026.
• Disclosure format: Press release summarizing Q2 2026 highlights furnished as Exhibit 99.1.
• Item: Disclosure made under Item 7.01 (Regulation FD Disclosure).

Why It Matters

• The Form 10-Q contains the company’s detailed quarterly results—including revenue, earnings (if reported), cash position, and discussion of operations and risks—so investors should review the 10-Q and the accompanying press release to see the specific financial and operational metrics for Q2 2026. This 8-K indicates Microbot is current with its SEC reporting and has publicly released its quarterly update under Regulation FD.